Launch of U.S.Focused RFP AI to Transform MedTech

Vamstar, the global leader in AI-powered commercialization solutions for life sciences, has announced the official launch of its U.S.-specific RFP AI platform. This new solution is designed to transform how MedTech companies compete for high-value contracts across the American healthcare system. The launch coincides with the opening of The MedTech Conference by AdvaMed in San Diego, one of the leading gatherings for executives shaping the future of healthcare technology.

The U.S. commercialization and procurement environment remains fragmented, compliance-heavy, and fiercely competitive. Every year, billions of dollars in contracts flow through federal systems such as SAM.gov, VA/DoD, as well as state and local agencies, hospital systems, and GPOs. Despite the size of the market, many MedTech suppliers continue to miss critical opportunities or struggle with complex compliance requirements, repetitive submissions, and lengthy review cycles.

Vamstar's new U.S. RFP AI addresses these challenges directly. The platform delivers full-spectrum discovery by scanning every U.S. procurement channel in real time, from federal portals to GPOs and IDNs. Compliance is built-in, embedding FDA, ISO, cybersecurity, and supply chain resilience documentation into every proposal. Cycle times are significantly reduced, with AI-driven drafting and collaboration tools accelerating RFQ and RFP responses by up to 50%. The platform also introduces smarter prioritization, ranking opportunities by fit, margin impact, and probability of success.

"Generic proposal platforms don't meet the demands of MedTech in the United States," said Praful Mehta, CEO of Vamstar. "Our RFP AI is healthcare-native by design. It gives commercial teams the visibility, speed, and compliance confidence they need to win more contracts and protect margins in a tightening market."

Vamstar's leadership team will be present in San Diego during the conference to provide exclusive, one-on-one demonstrations of the new platform for select MedTech executives.

Read more: https://vamstar.io/us/rfp-ai/

Vamstar Limited, 101 New Cavendish Street, London, W1W 6XH, United Kingdom.

Vamstar is the largest and fastest-growing AI-based global B2B healthcare supply chain platform. Using Machine Learning, Vamstar captures the demand for MedTech and Pharmaceutical products and services from 86000 buyers in 100+ countries and then matches this demand across the entire supplier base. Both buyers and suppliers across the industry use the platform to improve transaction and trading processes, capture real-time market insights (suppliers, products, and outcomes), launch better RFx and other sourcing programs, improve tender performance from the buyer-and-the-supplier side, and integrate ERP, CRM, and other downstream and upstream systems for full supply chain visibility. The platform connects pharmaceutical and medical device companies with public and private buyers, including corporates, clinics, hospitals, health insurance companies, and Group Purchasing Organisations (GPOs). Vamstar has sites in the United Kingdom, India, UAE, Netherlands, and the USA.

This release was published on openPR.